Polenal Forte™ contains Graminex Flower Pollen Extract G63™,
a patented ingredient from Graminex USA that helps maintain
a healthy prostate.
Polenal Forte™ contains 500 mg per dosage (2 tablets) of the patented ingredient Graminex Flower Pollen Extract G63™ with proven benefits on prostate health. The main ingredient is a concentrated flower pollen extract Secale Cereale L.
The contained natural ingredient promotes prostate health and function, helps reduce bladder discomfort and promotes urinary flow.
Flower pollen extract has clinical studies for successfully treating LUTS (Lower urinary tract symptoms) and BPH symptoms.
The unique chemical composition of the G63™ Flower Pollen Extract formula has been extensively studied for both safety and efficacy. In addition to this, G63™ Flower Pollen Extract has undergone complete toxicology studies.
Flower Pollen Extract is supported by over 100 clinical studies for various applications. These studies demonstrate the effectiveness of the product at varying dosages.
As a natural botanical extract, G63™ Flower Pollen Extract may be used in combination with other dietary supplements and pharmaceuticals to help provide relief for men experiencing bothersome BPH symptoms.
G63™ Flower Pollen Extract is a standardized product that meets the exact specifications for phytosterol and amino acid content for every batch. It is manufactured using a combination of the water soluble, G60™ Flower Pollen Extract, and the lipid soluble, GFX™ Flower Pollen Extract, portions of the pollen grain. G60™ contains a standardized portion of amino acids and GFX™ contains a standardized portion of phytosterols. These two ingredients are blended into a 20:1 ratio to create a standardized, pharmaceutical grade powder.
Contains Non-Solvent Graminex Flower Pollen Extract G63™, 250 mg per tablet, a total of 500 mg in a daily dosage.
Clinical studies have proven the positive benefits of flower pollen extract on prostate health and in treatment of LUTS (Lower urinary tract symptoms) and BPH (Benign Prostatic Hyperplasia) symptoms.
The minimum daily dosage is 500 mg or 2 tablets per day. Primary research as a pharmaceutical treatment has been conducted using a dose of 1500 mg/day. Independent clinicals conducted have used a range of 500-1500 mg/day.